A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study - Begoña Martin-Castillo, Sonia Pernas, Isabel Álvarez, Susana Martínez, Jose Manuel Pérez-Garcia, Joan Dorca, César A. Rodríguez-Sánchez, Maria Luque, Norberto Batista-López, Agostina Stradella, Kepa Amillano, Idoia Morilla, Severina Domínguez, Gemma Viñas, Sara Verdura - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

Published in

Impact Journals, Oncotarget, 86(9), p. 35687-35704, 2018

DOI: 10.18632/oncotarget.26286

Links

Tools

Export citation

Search in Google Scholar

A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study

Journal article published in 2018 by Begoña Martin-Castillo, Sonia Pernas, Isabel Álvarez, Susana Martínez, Jose Manuel Pérez-Garcia, Joan Dorca, César A. Rodríguez-Sánchez, Maria Luque, Norberto Batista-López, Agostina Stradella, Kepa Amillano, Idoia Morilla, Severina Domínguez, Gemma Viñas, Sara Verdura and other authors.

This paper is made freely available by the publisher.

This paper is made freely available by the publisher.

Full text: Download

Red circle

Preprint: archiving forbidden

Red circle

Postprint: archiving forbidden

Green circle

Published version: archiving allowed

Upload

Policy details

Data provided by

SHERPA/RoMEO